Mechanisms of Intestinal Barrier Dysfunction in Sepsis

Shock

Volumn 46, Issue 1, 2016, Pages 52-59

  Yoseph, Benyam P ^a   Klingensmith, Nathan J ^a   Liang, Zhe ^a   Breed, Elise R ^a   Burd, Eileen M ^b   Mittal, Rohit ^a   Dominguez, Jessica A ^c   Petrie, Benjamin ^d   Ford, Mandy L ^b   Coopersmith, Craig M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Barrier; cecal ligation and puncture; claudin; gut; intestine; JAM A; occludin; permeability; pneumonia; sepsis; ZO

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 13; CLAUDIN 15; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; CLAUDIN 8; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; JUNCTIONAL ADHESION MOLECULE A; OCCLUDIN; PROTEIN ZO1; UNCLASSIFIED DRUG; TIGHT JUNCTION PROTEIN; TJP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; ENTEROPATHY; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINAL BARRIER DYSFUNCTION; INTESTINE MUCOSA PERMEABILITY; LAPAROTOMY; MOUSE; NONHUMAN; PSEUDOMONAS PNEUMONIA; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SHAM PROCEDURE; WESTERN BLOTTING; ANIMAL; CECUM; GENETICS; INJURIES; INTESTINE PERFORATION; LIGATION; MALE; METABOLISM; PATHOLOGY; PNEUMONIA; PSEUDOMONAS INFECTION; TIGHT JUNCTION;

ANIMALS; CECUM; CLAUDINS; FEMALE; INTESTINAL DISEASES; INTESTINAL PERFORATION; LIGATION; MALE; MICE; OCCLUDIN; PNEUMONIA; PSEUDOMONAS INFECTIONS; SEPSIS; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84975882706     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000565     Document Type: Article

References (35)

1. Gaieski DF, Edwards JM, Kallan MJ, Carr BG: Benchmarking the incidence and mortality of severe sepsis in the United States. CritCareMed 41:1167-1174, 2013.
2. Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, Osborn T, Lemeshow S, Chiche JD, Artigas A, et al.: Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 43:3-12, 2015.
3. McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, Turnbull IR, Dipasco PJ, Osberghaus WF, Sherman B, Martin JR, et al.: Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 38:223-241, 2010.
4. Fry DE: The generic septic response. Crit Care Med 36:1369-1370, 2008.
5. Grunwell JR, Weiss SL, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Shanley TP, et al.: Differential expression of the Nrf2-linked genes in pediatric septic shock. Crit Care 19:327, 2015.
6. Yoseph BP, Breed E, Overgaard CE, Ward CJ, Liang Z, Wagener ME, Lexcen DR, Lusczek ER, Beilman GJ, Burd EM, et al.: Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis. PLoS One 8(5):e62792, 2013.
7. Mittal R, Coopersmith CM: Redefining the gut as the motor of critical illness. Trends Mol Med 20:214-223, 2014.
8. Turner JR: Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799-809, 2009.
9. Odenwald MA, Turner JR: Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 11:1075-1083, 2013.
10. Nalle SC, Aimee KH, Edelblum KL, Joseph NE, Singh G, Khramtsova GF, Mortenson ED, Savage PA, Turner JR: Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease. Sci Transl Med 6:243-87, 2014.
11. Khounlotham M, Kim W, Peatman E, Nava P, Medina-Contreras O, Addis C, Koch S, Fournier B, Nusrat A, Denning TL, et al.: Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity 37:563-573, 2012.
12. Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, Williams IR, Koval M, Peatman E, Campbell JA, et al.: JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 204:3067-3076, 2007.
13. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR: Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73:283-309, 2011.
14. Perrone EE, JungE,Breed E,Dominguez JA,Liang Z, ClarkAT,DunneWM,Burd EM, Coopersmith CM: Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis. Shock 38:68-75, 2012.
15. Dominguez JA, Samocha AJ, Liang Z, Burd EM, Farris AB, Coopersmith CM: Inhibition of IKKbeta in enterocytes exacerbates sepsis-induced intestinal injury and worsens mortality. Crit Care Med 41::e275-e285, 2013.
16. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, Xu dZ, Deitch EA: Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141:481-489, 2007.
17. Chen C, Wang P, Su Q, Wang S, Wang F: Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS One 7:e34946, 2012.
18. Li Q, Zhang Q, Wang C, Liu X, Li N, Li J: Disruption of tight junctions during polymicrobial sepsis in vivo. J Pathol 218:210-221, 2009.
19. Puleo F, Arvanitakis M, Van GA, Preiser JC: Gut failure in the ICU. Semin Respir Crit Care Med 32:626-638, 2011.
20. Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA: Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) 23:107-111, 2013.
21. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in amurine cecal ligation and puncture model. Surgery 94:331-335, 1983.
22. Earley ZM, Akhtar S, Green SJ, Naqib A, Khan O, Cannon AR, Hammer AM, Morris NL, Li X, Eberhardt JM, et al.: Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation. PLoS One 10:e0129996, 2015.
23. Dominguez JA, Vithayathil PJ, Khailova L, Lawrance CP, Samocha AJ, Jung E, Leathersich AM, Dunne WM, Coopersmith CM: Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumonia. Shock 36:381-389, 2011.
24. Clark JA, Clark AT, Hotchkiss RS, Buchman TG, Coopersmith CM: Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 30:36-42, 2008.
25. Fox AC, Breed ER, Liang Z, Clark AT, Zee-Cheng BR, Chang KC, Dominguez JA, Jung E, Dunne WM, Burd EM, et al.: Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality. J Immunol 187:1950-1956, 2011.
26. Alam MA, Al-Jenoobi FI, Al-Mohizea AM: Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol 64:326-336, 2012.
27. Fox AC, Robertson CM, Belt B, Clark AT, Chang KC, Leathersich AM, Dominguez JA, Perrone EE, Dunne WM, Hotchkiss RS, et al.: Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis. Crit Care Med 38:886-893, 2010.
28. Fujita H, Chiba H, Yokozaki H, Sakai N, Sugimoto K, Wada T, Kojima T, Yamashita T, Sawada N: Differential expression and subcellular localization of claudin-7,-8,-12,-13, and-15 along the mouse intestine. J Histochem Cytochem 54:933-944, 2006.
29. Tamagawa H, Takahashi I, Furuse M, Yoshitake-Kitano Y, Tsukita S, Ito T, Matsuda H, Kiyono H: Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of claudin-4 at the apex of the dome region. Lab Invest 83:1045-1053, 2003.
30. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, Coopersmith CM: Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297:G471-G479, 2009.
31. Li Q, Zhang Q, Zhang M, Wang C, Zhu Z, Li N, Li J: Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J 275:411-420, 2008.
32. Li GX,Wang XM, Jiang T, Gong JF, Niu LY, Li N: Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling pathway. Eur J Pharmacol 730:1-7, 2014.
33. Zhou H, Liang H, Li ZF, Xiang H, Liu W, Li JG: Vagus nerve stimulation attenuates intestinal epithelial tight junctions disruption in endotoxemic mice through alpha7 nicotinic acetylcholine receptors. Shock 40:144-151, 2013.
34. Cauvi DM, Williams MR, Bermudez JA, Armijo G, De MA: Elevated expression of IL-23/IL-17 pathway-related mediators correlates with exacerbation of pulmonary inflammation during polymicrobial sepsis. Shock 42:246-255, 2014.
35. Hamarneh SR, Mohamed MM, Economopoulos KP,Morrison SA, Phupitakphol T, Tantillo TJ, Gul SS, Gharedaghi MH, Tao Q, Kaliannan K, et al.: A novel approach to maintain gut mucosal integrity using an oral enzyme supplement. Ann Surg 260:706-714, 2014.